VYNE Therapeutics Inc

XNAS: VYNE

Download real time

0.95 -0.01 (-1.04%)

New 52W Low today

91,738 XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

15.8

Market Cap

Low in industry

0.2

Beta 1Year

Very Low volatility

VYNE Therapeutics Inc - VYNE - stock price prediction, stock price target, analyst ratings from 4 analysts

VYNE Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of 40.0%, and profit growth estimate of 1.2% for FY25, based on top 4 analyst calls.

Forecaster Screeners